
Sinovac Biotech, Ltd
SVA
SVA: Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
moreShow SVA Financials
Recent trades of SVA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SVA's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on SVA's company Twitter account
Number of mentions of SVA in WallStreetBets Daily Discussion
Recent insights relating to SVA
Recent picks made for SVA stock on CNBC
ETFs with the largest estimated holdings in SVA
Flights by private jets registered to SVA